Given a reduction in tumor size following one cycle of chemotherapy and the worse prognosis associated with liver metastasis from lung cancer compared to other sites (13), from February 27 to April 14, 2021, the patient received two cycles of systemic chemotherapy, including albumin-bound paclitaxel (400 mg on day 1) and cisplatin (30 mg on days 1 and 2), followed by transcatheter arterial chemoembolization (TACE) with cisplatin (60 mg) and albumin. The gene discussed is ALB; the disease is lung cancer.